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Two chapters in this volume deal with Immunology of Infectious Diseases
and Vaccines. Only 5% to 10% of immunocompetent humans are susceptible
to tuberculosis, and over 85% of them develop the disease exclusively in the
lungs. Tuberculosis in mice is also exclusively a lung disease that is progressive
and lethal, in spite of the generation of Th1- mediated immunity. In a very
interesting issue, R.J. NORTH & Y-J. JUNG first argue that mouse tuberculosis
and tuberculosis in guinea pig and rabbit are models of tuberculosis in
susceptible humans. Second, the authors discuss that inability to resolve
infection and prevent disease may not be a consequence of the generation of
an inadequate number of Th1 cells but of an intrinsic deficiency in macrophage
function that prevents these cells from expressing immunity. The purpose of
immunological memory is to protect a host from reinfection, to control
persistent infection, and to protect immunologically immature fetuses and
neonates by passive transfer of maternal antibody. Based on experimental
models, R.M. WELSH et al. describe how T and B cell memory is generate in
response to virus infections and how these cells respond when the host is
infected again by similar or different viruses. They conclude that although
armed with highly distinct effector functions, there are many parallels between
the T cell and B cell components of the immune response and their conversion
into memory. The authors also argue that memory B and T cell responses are
long-lived in the absence of antigen, but they are modulated and influenced
by other infections and that memory B and T cells can either provide protective
immunity or contribute to immunopathology on infection with homologous
or heterologous viruses.
The area of Lymphocyte Development and Differentiation has been
the target for several publications in previous volumes of this scientific
series. Efficient recognition of foreign pathogens by T cells requires adhesive
interactions between T cells and other cell types, such as endothelial cells
and antigen-presenting cells (APCs), and with components of the
extracellular matrix. J.T. PRIBILA et al. discuss the role of integrins in T
cell- mediated immunity, with a focus on how these receptors participate in
lymphocyte recirculation and T cell activation, how antigen stimulation
regulates integrin activity, and how integrins define functionally unique
subsets of T cells and APCs. Although NK cells play important roles in host
defense against various infectious agents, they are critical in host defense
against viral infections. In a very didactic way, W.M. YOKOYAMA et al.
provides an overview of the dynamic in vivo life of NK cells from their
development in the bone marrow to their mature cellular responses in the
periphery and their ultimate demise, with emphasis on mouse NK cells and
viral infections. Memory is the hallmark of the acquired immune system. In
the B cell system protective memory is mediated by plasma cells that secrete
antibodies, whereas reactive memory is mediated by memory B cells that
proliferate and differentiate to plasma cells in response to secondary antigenic
stimulation. Recent studies indicate that memory T lymphocytes contain
distinct populations of central memory (T
CM
 cells) and effector memory
(T
EM
) cells characterized by distinct homing capacity and effector function.
In a very interesting chapter, F. SALLUSTO et al. review the heterogeneity
of the current models for memory T cells generation and maintenance in
humans and mice. Investigators would like to understand how T cells live
and die in the intact animal. Numerous experiments show that the factors
affecting T cell viability vary depending on the type and status of the T cell
involved. In a very interesting review, P. MARRACK & J. KAPPLER focus
on naïve, activated, and memory T cells survival separately, and discuss
experiments done in vitro and in mice lacking or containing normal
populations of lymphocytes. Finally, M. BUSSLINGER focuses on the
transcription factors that regulate early B-lymphopoiesis in the bone marrow.
Much information has been obtained on the area of Phagocytosis and
Inflammation. In a very exciting issue, G. WICK et al. put out new autoimmune
hypothesis for atherogenesis in the context of many data that speak for an
important role of inflammatory-immunologic processes. The authors focus
on the concept that cellular and humoral immunity to the phylogenetically
highly conserved antigen heat shock protein 60 (HSP60) is the initiating
mechanism in the earliest stages of atherosclerosis. The discovery that the Toll
and img pathways are required for defense against fungal and bacterial
infection in Drosophila was pivotal in studies of both mammalian and
Drosophila immunity. In an interesting chapter, C.A. BRENNAN & K.V.
ANDERSON review the Drosophila genetics of innate immune recognitions
and regulation of immune responses. As the authors anticipate, one of the
future researches in the Drosophila immunity is likely to define mechanisms
that allow Drosophila blood cells may carry out a form of self-nonself
recognition that is independent of microbial pattern recognition. Trauma and
infection may result in excessive collateral damage to normal tissues, and the
failure to control activated immune cells may cause diseases as cancer, heart
disease, atherosclerosis, and sepsis. M.V. SITKOVSKY et al. focus on the
search for the physiological mechanisms (“OFF signals”) that limit collateral
tissue damage by immune cells including extracellular adenosine and
immunosuppressive A
2A
 adenosine receptors. Targeting A
2A
receptors by
pharmacologically enhanced levels of endogenously formed adenosine and
the combined use of selective A
2A
agonists with anti-inflammatory and
pathogen-destroying drugs in clinical applications are also discussed. Human
vascular endothelial cells (EC) basally display Class I and II MHC-peptide
complexes on their surface and come in regular contact with circulating T
cells. J. CHOI et al. propose that EC present microbial antigens to memory T
cells as a mechanism of immune surveillance. The authors describe both how
EC can activate T cells by presenting antigens and how T cells can modify
crucial EC functions, including antigen presentation. Because EC in various
vascular beds differ in their properties, an attractive consideration of EC
heterogeneity is discussed.
Two chapters are dedicated to Regulation of the Immune System. In
the 1960s, J. Gowars discovered that lymphocytes recirculate from the
blood into lymphoid organs (“homing”) and back to the blood. Taking a
monoclonal antibody strategy to decipher the molecular basis of this
interaction, Gallatin et al. discovered a cell surface antigen on lymphocytes.
Finally, the subsequent cloning of this molecule led to the identification of
L-selectin (CD 62L). Beyond its general role in lymphocyte homing to
secondary lymphoid organs, L-selectine is implicated in inflammatory
processes, hematogenous metastasis of carcinoma cells, and implantation of
early mammalian embryo. The current knowledge about the ligands engaged
by L-selectin during normal and pathological processes is reviewed by S.
ROSEN. CD40/CD154 interactions govern both the magnitude and quality
of humoral- and cell-mediated immunity. Many effector mechanisms of
inflammation are abolished as a result of CD154 blockade, but there is
evidence that CD154 blockade may, in some instances, engender long-
lived, antigen-specific tolerance. S. A. QUEZADA et al. present and discuss
the prospects for inducing long-lived antigen-specific tolerance in a model
of allograft tolerance through CD154 blockade.
The area of Cytokines is examined in three chapters. Mammals generate
a diverse array of antimicrobial proteins, represented by defensins or
cathelicidins. D. YANG et al. discuss defensines and also outline the multiple
effects of cathelicidins and eosinophil-derived neurotoxin (EDN) on host
immune cells and their roles in innate and adaptive antimicrobial immunity.
Chemokines compose a sophisticated communication system used by all
cell types, including immune cells. In a very interesting issue, A. ROT &
U.H. von ANDRIAN summarize current understanding of the mechanisms
that regulate the cellular perception and pathophysiologic meaning of
chemokines. As pointed out by the authors, like any other communication
system the chemokine network bears several noteworthy attributes of a
language, which they call the “Chemokinese”. In a very exciting issue, the
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basic general rules of the “grammar of “Chemokinese” and how it applies to
cell communication in the process of inflammation and immune responses
are discussed. Finally, S. PESTKA et al. provide a comprehensive analyses
of Class 2 -helical cytokines (IL-10, IL-19, IL-20, IL-22, IL-24, and IL-
26), interferons and interferon- like molecules, and related receptors. The
authors focus on evolution and crystal structures of these molecules providing
insights and perspective into the immunology of these proteins.
Two chapters in this volume deal with Autoimmunity. How self-tolerance
is achieved has been a key issue in immunology for nearly 50 years since
the proposition of the clonal selection theory. Among the mechanisms of
immunologic self-tolerance, the contribution of regulatory T cells (T
R
 cells)
or even their existence as a cellular entity has been controversial until
recently. T
R
 cells are heterogeneous in phenotype, function, and the way of
generation. Some are naturally occurring; others are induced by specific
ways of antigenic stimulation. Genetic defects that primarily affect their
development or function can indeed be a primary cause of autoimmune
and other inflammatory disorders in humans. In his excellent chapter, S.
SAKAGUSHI discuss how naturally arising CD25+CD4+ T
R
 cells contribute
to the maintenance of self-tolerance and negative control of various immune
responses and how they can be exploited to prevent and treat autoimmune
disease, allergy, cancer, and chronic infection, or establish donor-specific
tolerance. The evidence is overwhelming from both the clinical observations
and animal models that the classical complement pathway proteins play a
protective role against the development of systemic lupus erythematosus
(SLE). In an up-to-date chapter, A.P. MANDERSON et al. first discuss
clinical associations between the complement system and SLE. Second,
they review finding from animals with complement deficiency that has
confirmed the link between deficiency of classical pathway proteins and
predisposition to the development of SLE. Finally, the authors focus on the
hypothesis that has been advanced to explain these associations.
The intestine of higher vertebrates has three defined anatomical
compartments which contain T lymphocytes. The gut-associated lymphoid
tissues (GALT), including Peyer´s patches and mesenteric lymph nodes,
contain T cells in organized lymphoid structures. The lamina propria harbors
T cells scattered among nonlymphoid cell types. Finally, numerous
intraepithelial lymphocytes (IEL) reside as single cells between the intestinal
epithelial cells. There is several evidence that the IEL provide qualitatively
and quantitatively major contributions to the biology of the mucosal and
systemic immune systems. H. CHEROUTRE discusses the biology of IEL,
with an emphasis on the subsets that express an TCR, and their key role
in the unique intestinal defense mechanisms that have evolved in mammals.
The field of Immunodeficiency includes only one excellent chapter by
R. BUCKLEY. Human severe combined immunodeficiency (SCID) is a
pediatric emergency. Infants with this condition are profoundly lymphopenic
and may die of infection before their fist or second birthdays. It is now
know that SCID can be caused in humans by mutations in at least nine
different genes. Approaches to immune reconstitution have included bone
marrow transplantation and gene therapy. Many studies clearly demonstrate
that transplantation of T cell-depleted HLA-identical or HLA-haploidentical
bone marrow is highly effective in reconstituting T cell immunity in all of
the known genetic types of SCID. Because of serious adverse events,
retroviral gene therapy trials are currently on hold. In a didactic way, R.
BUCKLEY reviews molecular defects in human SCID and discusses current
progress in immune reconstitution.
Asthma is a result of airway inflammation and remodeling. Th2 cells
are continually active in the airways, even when disease is quiescent. These
cells contribute to the inflammatory response and to airway remodeling by
producing cytokines. IL-13 is the key effector cytokine in asthma and
stimulates airway fibrosis through the action of matrix metalloproteinases
on TGF-  and promotes epithelial damage, mucus production, and
eosinophilia. IL-4, IL-5, and IL-13 produced by non-TCD4 cells may be
essential for the development and perpetuation of asthma. L. COHN et al.
review some of the mechanisms by which inflammatory and structural cells
in the airways communicate to intensify disease and ultimately promote
persistence and progression of asthma.
In the area of Tumor Immunology, S. WON & O.N. WITTE focus on
the impact that imatinib mesylate (a direct inhibitor of ABL, ARG, KIT, and
PDGFR tyrosine kinases) has had on the treatment of chronic myelogenous
leukemia (CML) as well as other blood neoplasia and solid tumors with
etiologies based on activation of tyrosine kinases. The concept that the
immune system can recognize and eliminate primary developing tumors in
the absence of external therapeutic intervention has existed for nearly 100
years. Most recently, it was demonstrated that the immune system not only
can protect the host against tumor development but also, by selecting for
tumors of lower immunogenicity, has the capacity to promote tumor growth.
These dual effects of the immune system on developing tumors prompted
G.P. DUNN et al. to refine the cancer immunosurveillance hypothesis into
one they termed cancer immunoediting. In a very interesting chapter, the
authors define and discuss the three Es of cancer immunoediting: elimination,
equilibrium, and escape.
The field of MHC is examined in two chapters. Dendritic cells (DCs)
are highly efficient antigen-presenting cells (APCs) that collect antigen in
body tissues and transport them to draining lymph nodes. DCs are well
equipped to distinguish between self- and nonself- antigens by the variable
expression of cell-surface receptors such as C-type lectin receptors (CLRs)
and Toll-like receptors (TLRs). There is evidence that in the stead state, DCs
are not immunologically quiescent but use their antigen-handling capacities
to maintain peripheral tolerance. In contrast, efficient antigen-specific
immune activation occurs upon encounter of DCs with nonself-pathogens.
T.B.H. GEIJTENBEEK et al. propose the hypothesis that cross talk between
TLRs and CLRs, differentially expressed by subsets of DCs, accounts for
the different pathways to peripheral tolerance, such as deletion and
suppression, and immune activation. CD1-restricted T cells carry out effector,
helper, and adjuvant-like functions and interact with other cell types including
macrophages, dendritic cells, NK cells, T cells, and B cells, thereby
contributing to both innate and adaptive immune responses. In an up-to-
date chapter, M. BRIGL & M.B. BRENNER first summarize the major
features of CD1 genes and proteins, the patterns of intracellular trafficking
of CD1 molecules, and how they sample different intracellular compartments
for self- and foreign lipids. Second, the function of CD1-restricted T cells in
antimicrobial response, antitumor immunity, and in regulation of balance
between tolerance and autoimmunity is discussed.
Like all other antibodies self-reactive antibodies are produced in
developing B cells by V(D)J recombination in the bone marrow. In the past
20 years transgenic experiments in mice have shown that at least three
mechanisms regulate auto-reactive antibodies during B cell development:
receptor editing, deletion, and anergy. The prevalence of autoantibodies in
the initial antibody repertoire, their regulation by receptor editing, and the
role of the recombinase proteins (RAG1 and RAG2) in this process are
reviewed by M. JANKOVIC et al.
In the area of Lymphocyte Surface Antigens and Activation Mechanisms
current understanding of E3 ubiquitin ligases in both innate and adaptive
immunity is summarized by Y-C LIU. Cytokines are crucial to maintaining
healthy and play also an important role in the onset and progression of
disease. It has become clear that cells have evolved sophisticated mechanisms
to prevent excessive responses to cytokines. In a very interesting chapter,
W.S. ALEXANDER & D.J. HILTON focus on the suppressors of cytokine
signaling (SOCS) family of cytoplasmatic proteins that completes a negative
feedback loop to attenuate signal transduction from cytokines that act through
the janus kinase / signal transducer and activator of transcription (JAK/STAT)
pathway. Recent advances in the understanding of phosphoinositide 3-kinase
(PI3K) signaling mechanisms in different immune cells and receptor systems
are reviewed by J.A. DEANE & D.A. FRUMAN.
Finally, the prefatory chapter “Genetics, FACS, Immunology, and Redox:
a tale of two lives intertwined” written by LEONARD A. HERZENBERG &
LEONORE A. HERZENBERG is obligatory to all readers.
This volume of the Annual Review of Immunology offers a broad updated
information on selected topics for students and researchers focusing recent
progress on Basic and Clinical Immunology in a didactic manner of presentation.
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